+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cyclosporin A pharmacokinetics in liver transplant recipients effect of ursodeoxycholic acid



Cyclosporin A pharmacokinetics in liver transplant recipients effect of ursodeoxycholic acid



Gastroenterology 118(4 Suppl 2 Part 1): AASLD A984




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 034672673

Download citation: RISBibTeXText

DOI: 10.1016/S0016-5085(00)86082-5


Related references

Ursodeoxycholic acid modulates cyclosporin A oral absorption in liver transplant recipients. Fundamental & Clinical Pharmacology 14(6): 601-609, November-December, 2000

Ursodeoxycholic acid modulates cyclosporin A oral absorption in liver transplant recipients. Fundamental and Clinical Pharmacology 14(6): 601-609, 2001

Effect of ursodeoxycholic acid treatment for cholestasis in liver transplant recipients. Transplantation Proceedings 27(6): 3501-3502, 1995

Pharmacokinetics of a new oral formulation of cyclosporin in liver transplant recipients. Therapeutic Drug Monitoring 17(3): 213-216, 1995

Cyclosporin A pharmacokinetics in liver transplant recipients in relation to biliary T-tube clamping and liver dysfunction. Gut 30(3): 391-396, 1989

Pharmacokinetics of cyclosporin after intravenous and oral application in liver transplant recipients. Naunyn-Schmiedeberg's Archives of Pharmacology 341(SUPPL): R110, 1990

Comparison of pharmacokinetics of mycophenolic acid and its metabolites between living donor liver transplant recipients and deceased donor liver transplant recipients. Liver Transplantation 15(11): 1473-1480, 2010

Ursodeoxycholic acid for prevention of acute rejection in liver transplant recipients. Lancet 336(8706): 52-53, 1990

Adjuvant ursodeoxycholic acid prevents acute rejection in liver transplant recipients. Transplantation Proceedings 23(3): 1971, 1991

Does adjuvant ursodeoxycholic acid prevent early rejection in liver transplant recipients. Gastroenterology 98(5 PART 2): A587, 1990

Ursodeoxycholic acid prevents steroid resistant rejection in liver transplant recipients. Gastroenterology 108(4 SUPPL ): A1168, 1995

Ursodeoxycholic acid as an immunosuppressant sparing agent in non tolerant long-term liver transplant recipients. Gastroenterology 116(4 PART 2): A1289, 1999

Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid. Transplantation 83(12): 1571-1576, 2007

Effect of oral terbinafine treatment on cyclosporin pharmacokinetics in organ transplant recipients with dermatophyte nail infection. Acta Dermato-Venereologica 76(4): 280-281, 1996

Mycophenolic acid and mycophenolic acid glucuronide pharmacokinetics in pediatric liver transplant recipients: effect of cyclosporine and tacrolimus comedication. Therapeutic Drug Monitoring 24(5): 598-606, 2002